The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Oct. 27, 2020
Filed:
Dec. 05, 2019
Pfizer Inc., New York, NY (US);
Kathrin Ute Jansen, New York, NY (US);
Annaliesa Sybil Anderson, Upper Saddle River, NJ (US);
Judith Absalon, New York, NY (US);
Jose Miguel Aste-Amezaga, Harleysville, PA (US);
Johannes Frederik Beeslaar, Farnham, GB;
David Cooper, Monroe, NY (US);
John Erwin Farley, Chapel Hill, NC (US);
Leah Diane Fletcher, Genesco, NY (US);
Shannon Lea Harris, Nanuet, NY (US);
Thomas Richard Jones, Bluffton, SC (US);
Isis Kanevsky, New York, NY (US);
Lakshmi Khandke, Nanuet, NY (US);
Paul Liberator, Holmdel, NJ (US);
John Lance Perez, Doylestown, PA (US);
Lynn Marie Phelan, Lake Hiawatha, NJ (US);
Gary Warren Zlotnick, San Antonio, TX (US);
Pfizer Inc., New York, NY (US);
Abstract
In one aspect, the invention relates to a composition including a factor H binding protein (fHBP) and anon-serogroup B capsular polysaccharide. The invention further relates to uses of a composition that includes fHBP, such as, for example, uses to elicit an immune response againstserogroup B strains and non-serogroup B strains. The compositions and methods described herein are directed to administration in humans, including adults, adolescents, toddlers, and infants.